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Targeting the endoplasmic reticulum with a membrane-
interactive luminescent ruthenium(II) polypyridyl
complex†
Martin R. Gill,ab Denis Cecchin,c Michael G. Walker,a Raminder S. Mulla,a
Giuseppe Battaglia,*c Carl Smythe*b and Jim A. Thomas*a
The characterization and bioactivity of the dinuclear ruthenium(II) complex [(Ru(DIP)2)2(tpphz)]
4+ (DIP ¼
4,7-diphenyl-1,10-phenanthroline and tpphz ¼ tetrapyrido[3,2-a:20,30-c:30 0,20 0-h:20 0 0,30 0 0-j]phenazine) is
reported. This new complex is found to be luminescent in acetonitrile, where excitation into MLCT
(metal-to-ligand charge-transfer) bands in the visible area of the spectrum (lex ¼ 450 nm, 3 ¼ 45 000
M1 cm1) result in red emission (lem,max ¼ 620 nm, FMLCT ¼ 0.017). Aqueous in vitro binding studies
indicate that this complex binds to duplex DNA with an aﬃnity of 1.8  106 M1 through a non-
classical groove-binding interaction, however, unlike the parent complex [(Ru(phen)2)2(tpphz)]
4+ (phen
¼ 1,10-phenanthroline), it also displays an increase in MLCT luminescence on addition of liposomes.
Confocal microscopy and TEM studies show that this lipophilic complex targets the endoplasmic
reticulum of eukaryotic cells, where it functions as an imaging agent for this organelle, and cytotoxicity
studies in human cancer cell lines indicate a comparable potency to the anti-cancer drug cisplatin.
Introduction
Insight into how membrane-enclosed intracellular structures
and organelles interact and are regulated within eukaryotic cells
is of vital importance within cell biology and medicine.1 Argu-
ably the two most notable organelles within the membrane-
dense intracellular network are the endoplasmic reticulum (ER)
and the Golgi apparatus. Apart from being involved in the
assembly and transport of proteins, the ER also plays a key role
in response to cellular stress, whilst the Golgi apparatus func-
tions as an organisational centre for the cell.
The visualization of cellular structure by light microscopy
remains a powerful research tool and, considering the number of
commercially-available probes for DNA, there are very few small
molecule analogues for ER and/or Golgi visualization. ER dyes
include the lipophilic green-emissive DiOC6 (3,30-dihexylox-
acarbocyanine iodide) and the ER-tracker series, which consist of a
boron-dipyrromethane (BODIPY) uorophore conjugated to
glibenclamide, a drug which targets ATP-sensitive K+ channels
found in a high frequency on the ER.2 Disadvantages of these
current commercial stains include small Stokes shi values (DiOC6
¼ 19 nm, ER Tracker Green ¼ 7 nm, ER Tracker Red ¼ 28 nm),
and, in the case of DiOC6, additional mitochondrial targeting.
With the limitations of organic uorophores in mind, there
has been great interest in luminescent transition metal
complexes as cellular imaging agents for optical microscopy.3–5
RuII-based polypyridyl complexes are particularly attractive as
their MLCT (metal-to-ligand charge-transfer)-based lumines-
cence typically exhibit large Stokes shis (i.e. >100 nm), acces-
sible excitation energies in the visible (blue) region of the
spectrum combined with red or far-red emission. These factors
are advantageous as they mean that these complexes are
compatible with existing experimental equipment, can be used as
co-stains alongside established commercial uorophores, and
may negate problems resulting from cellular autouorescence.
Since the discovery that [Ru(bpy)2(dppz)]
2+ (bpy ¼ 2,20-
bipyridine, dppz ¼ dipyrido[3,2-a:20,30-c]phenazine) binds with
high aﬃnity to DNA and functions as a luminescence-based
“light switch” (in which quenched luminescence in aqueous
environment is activated upon non-covalent reversible DNA
binding),6 a huge number of studies based on the interaction of
octahedral ruthenium(II) polypyridyl complexes with DNA have
been published.7,8 In contrast, analogous in vitro interaction of
RuII complexes with phospholipids and other self-assembling
membrane structures has remained relatively unexplored.
However, it is known that [Ru(bpy)2(dppz)]
2+ itself functions as
a luminescent indicator for sodium dodecyl sulfate micelle
formation9 and a probe of lipid dynamics.10 More recently, the
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interaction of lipophillic RuIIdppz derivatives with lipid
membranes has been explored.11,12 In these studies, it was
found that the attachment of progressively longer alkyl chains
to the dppz moiety resulted in a concomitant increase in
membrane aﬃnity.
In cellular studies, while a small number of luminescent RuII
polypyridyl compounds capable of targeting nuclear DNA have
been reported,13 studies into the cellular internalization of
lipophilic luminescent RuII systems have frequently revealed
non-nuclear localizations.14–18 While exact cellular targets have
generally remained uncharacterized, membrane targeting has
been strongly suggested in certain cases.19–22 This work clearly
illustrates the potential for utilizing the photophysical proper-
ties of these complexes for the in vitro and in cellulo study of
membrane structures.
Previously, we have reported on the cellular uptake proper-
ties of the dinuclear RuIItpphz complex [(Ru(phen)2)2(tpphz)]
4+
(phen ¼ 1,10-phenanthroline, tpphz ¼ tetrapyrido[3,2-a:20,30-
c:30 0,20 0-h:20 00,30 0 0-j]phenazine), 1, demonstrating this lumines-
cent light switch complex functions as a DNA imaging agent
(Scheme 1).23 In this study, we describe a lipophilic derivative of
1, [(Ru(DIP)2)2(tpphz)]
4+ (DIP ¼ 4,7-diphenyl-1,10-phenanthro-
line), 2, which is designed to localize within membrane struc-
tures; its in vitro interaction with both DNA and liposomes are
reported and the potential of this complex for visualizing lipo-
philic intracellular structure by uorescence (confocal) imaging
and electron microscopy is assessed.
Results and discussion
Synthesis and characterisation of target complex
Previous studies have established that complex 1 targets the cell
nucleus, where it binds to duplex DNA through reversible
interactions.23 We reasoned that if the steric demands of this
complex were greatly increased through larger ancillary ligands,
then binding into duplex grooves would become increasingly
unlikely. Aside from disfavouring DNA binding, the employ-
ment of more extended aromatic ancillary ligands would
increase the lipophilicity of the nal complex, thus favouring
binding to lipid-based structures. Therefore, with these criteria
in mind, the synthesis of complex 2 was carried out by adapting
a previously reported method.24 The central tpphz bridging
ligand was retained to facilitate the generation of an MLCT-
active luminescent compound.25 The use of DIP as an ancillary
ligand had the intended eﬀect on lipophilicity: for 2 the esti-
mated octanol–water partition coeﬃcient, log P, is 1.52  0.13,
compared to 0.93 for 1. An unavoidable drawback of this
increase in the lipophilicity of 2 is that the complex displays
relatively poor solubility in pure water, even as a chloride or
nitrate salt. Accordingly, DMSO was employed to prepare
working stock solutions of 2, nevertheless the percentage of
DMSO was kept to a maximum of 1% in the live cell uptake and
cytotoxicity studies.
The absorption and emission (lex ¼ 450 nm) spectra of 2 in
acetonitrile are shown in Fig. 1. The electronic absorption
spectrum for the complex displays high energy bands at 280 and
314 nm that are assigned to ligand-centred p/ p* transitions,
whilst the broad, low energy absorbances between 350 and
550 nm are characteristic of metal-to-ligand charge-transfer
transitions from the RuII metal centres to the polypyridyl
ligands. Complex 2 is luminescent in acetonitrile: 1MLCT exci-
tation at 446 nm leads to 3MLCT-based emission centred at
620 nm, and the quantum yield for this emission is FMLCT ¼
0.017  0.002. This compares to a value of FMLCT ¼ 0.005 for 1
for an emission maxima centred at 690 nm.26 The increase in
quantum yield and blue-shied emission demonstrated by 2 are
consistent with the energy gap law and suggest the ancillary
ligands have a considerable eﬀect on the MLCT excited state,
consistent with our previous studies on Ru(dppz)-based systems
incorporating extended polypyridyl ligands.27
In vitro interaction with DNA or liposomes
Considering that 1 binds reversibly to duplex DNA with a high
binding aﬃnity,28 the ability of 2 to interact with DNA in vitro
was investigated. Of particular interest was the question of how
the extended aromatic ligand DIP would aﬀect binding towards
DNA in comparison to 1. Changes in the UV-visible absorption
spectrum of 2 upon the addition of increasing concentrations
of calf thymus DNA resulted in appreciable hypochromicity for
both p/ p* and MLCT absorption bands of 2 (Fig. 2a). The
changes in the p/ p* band successfully yielded a saturation
Scheme 1 Dinuclear RuII complexes 1 and 2.
Fig. 1 Absorption and emission (lex ¼ 450 nm) spectra of 2 in acetonitrile. The
excitation spectrum (lem ¼ 620 nm) is included for comparison.
This journal is ª The Royal Society of Chemistry 2013 Chem. Sci., 2013, 4, 4512–4519 | 4513
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ligand–DNA binding curve (Fig. 2a, inset) and, by tting these
binding data to the McGhee von Hippel model,29 a derived
binding constant, Kb¼ 1.8  106 M1 with a binding site size, S
¼ 2.01 (in base pairs) was obtained. These results can be
compared to Kb ¼ 1.1  107 M1 and S ¼ 2.6 previously
reported for 1,28 indicating 2 binds DNA an order of magnitude
weaker than the parent complex. As can be seen in Fig. 2b, the
interaction of 2 with DNA is accompanied by a two-fold
enhancement of MLCT luminescence emission. This may be
compared to a 60-fold increase demonstrated for 1.28 Attempts
to t these small spectral changes to binding models failed to
produce reliable saturation binding curves and thus a DNA
binding constant could not be derived for 2 using this latter
technique.
It is known30–32 that intercalating moieties unwind DNA, thus
increasing relative viscosities of aqueous DNA solutions, while
groove-binding molecules demonstrate no such eﬀect. There-
fore, to further explore the interaction of 2 and DNA, the relative
viscosity of calf thymus DNA upon the addition of 2 was
measured. 1 was included in these viscosity studies for
comparative purposes. Fig. 3a indicates that the addition of 1 to
DNA results in no change in the viscosity and, in contrast, the
addition of 2 to a DNA solution actually results in a decrease of
the specic viscosity (Fig. 3b). Taking Fig. 3a and b together, the
behaviour of 2 clearly does not correlate with either an inter-
calating or classical groove binding mode of interaction with
DNA. These results reveal that complex 1 is a groove-binding
molecule in a similar manner to the bpy (2,20-bipyridine)
analogue, [(Ru(bpy)2)2(tpphz)]
4+,33 and we conclude it is the
greater steric bulk of 2 that inhibits the ability of this complex to
associate with DNA through a canonical groove-binding inter-
action, resulting in a lower DNA binding aﬃnity for the
extended complex. Our viscosity studies indicate that complex 2
does distort the structure of DNA, and, in fact, the large dimi-
nution in relative viscosity observed indicates that 2 causes a
decrease in the hydrodynamic length of DNA. A similar eﬀect
has previously been documented for RuII partial intercalators
containing sterically hindering methyl groups34 as well as in our
work on DNA binding metallomacrocycles.35 Considering that
FeII helicates are able to induce intramolecular DNA coiling,
with an accompanying decrease in DNA length,36 it is possible
that 2 is similarly causing large scale bending of DNA. More
detailed studies into the exact nature of DNA binding by 2 will
form the basis of future work, however, in the remainder of this
report we will focus on the interaction of 2with bio-membranes.
Fig. 2 (a) Changes in UV-visible absorption spectrum of 2 (99% Tris buﬀer (5 mM
tris(hydroxymethyl)aminomethane, 25 mM NaCl, pH 7), 1% DMSO) with addition
of DNA, highlighting hypochromicity with increasing DNA concentration. Inset:
derived binding curve from these data. (b) Increase inMLCT luminescence of 2 (lex
¼ 450 nm) with the addition of DNA.
Fig. 3 (a) Plot of relative viscosity (h/h0)1/3 of DNA versus r (r¼ [complex]/[DNA])
upon addition of 1 (Tris buﬀer). (b) Plot of relative viscosity of DNA with addition
of 2 (1% DMSO, 99% Tris buﬀer). The intercalator ethidium bromide (EB) and the
groove binder Hoechst 33258 (H33258) were included for reference in both
experimental conditions.
4514 | Chem. Sci., 2013, 4, 4512–4519 This journal is ª The Royal Society of Chemistry 2013
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As discussed above, certain luminescent RuII polypyridyl
compounds have an aﬃnity for hydrophobic membranes. Since
2 is a hydrophobic molecule designed with this in mind, the in
vitro interaction 2 with DOPC (DOPC ¼ 1,2-dioleoyl-sn-glycero-3-
phosphocholine, also known as dioleoylphosphatidylcholine)
liposomes was then assessed. 1 was included as a hydrophilic
MLCT luminescent control. As Fig. 4 shows, complex 2 demon-
strates a clear increase in MLCT luminescence on addition of
liposomes. Based upon the well-established photophysical
properties of RuIItpphz systems, it would seem highly likely that
the interaction between 2 and liposomes results in increased
shielding of the complex from water, which induces the
observed increase in luminescence. In contrast, the addition of
liposomes to 1 produces no changes in luminescence – even
aer extended incubation times. These contrasting responses
indicate that the more lipophilic complex 2 interacts with lipo-
somalmembranes whereas no such interaction is observed for 1.
Clearly – since the hydrophobic complex 2 displays an MLCT
emission enhancement on association with liposomes – these
in vitro experiments suggest that complex 2 has potential to
target cellular membrane structures. This concept was
addressed through detailed in cellulo studies.
Cellular imaging studies
To facilitate detailed characterization of the imaging properties
and cellular localization prole of 2, MCF-7 human breast
cancer cells were xed utilizing two diﬀerent methods before
being exposed to solutions of the complex and visualized using
uorescence (confocal) microscopy. These studies particularly
focused on the exciting possibility that this lipophilic RuII
complex could behave as an MLCT imaging agent for lipid-
dense cellular structures. As shown by representative micro-
graphs in Fig. 5a, 2 is compatible with both formaldehyde and
ethanol xation. Fig. 5b and S1† demonstrate that 2 is
compatible with laser excitation at either 458 or 488 nm both of
which result in in cellulo emission centred at 640 nm, data in
agreement with our in vitro studies outlined above. As 488 nm
produces the optimal emission response in these microscopy
conditions, this corresponds to a de facto Stokes shi value of
152 nm for the cellular MLCT luminescence of 2. A detailed
examination of the cellular localization prole of 2 following
either xation method demonstrates that 2 facilitates the visu-
alization of specic internal cellular structures – of particular
interest is the clear denition of nuclear membrane and/or
perinuclear space.
To further explore intracellular cellular targeting, detailed
co-localization experiments in which the overlap of emissions
with established cellular uorescent staining techniques were
carried out. First, MCF-7 cells stained with 2 were co-stained
with the nuclear dye DAPI (40,6-diamidino-2-phenylindole).
Cellular co-localisation analysis of the two luminescence signals
reveals poor overlap of 2 and DAPI, indicating that the RuII
complex does not strongly co-localize with the DNA dye (Fig. 5c
and d). 1 was employed as a positive control for cellular DNA
targeting and the strong co-localization between DAPI emission
and the MLCT of 1 is evident (Fig. S2†). Combined with the
observation that aggregated metaphase chromosomes remain
unstained by 2 (Fig. S3†), this supplies compelling evidence that
the lipophilic RuII complex 2 does not target cellular DNA. This
behaviour is in agreement with our in vitro studies, and indi-
cates that the sterically bulky DIP ligands of 2 inhibit strong in
cellulo groove binding interactions with DNA.
As 2 is a lipophilic molecule which interacts strongly with
membrane structures in vitro, we hypothesized that the mole-
cule associates with lipophilic regions within the cell. There-
fore, co-localization experiments for the ER and Golgi
apparatus, two particularly lipid-dense organelles, were under-
taken to fully establish the nature of the intracellular localiza-
tion and emission of 2. Immunouorescent co-staining
techniques were employed, whereby MCF-7 cells stained with 2
were probed using specic antibodies for proteins that localize
in either the ER or Golgi apparatus; the cellular localization of
each antibody then visualized using FITC (uorescein iso-
thiocyanate)-conjugated secondary antibodies. As FITC (lex ¼
490 nm and lem ¼ 525 nm; a Stokes shi of 35 nm) is likewise
excited by 488 nm light, experiments to indicate that no bleed-
through between the emission signals of FITC and 2 were rst
conducted (Fig. S4†). These experiments validated this meth-
odology and, thanks to the signicantly red-shied emission
Fig. 4 In vitro interaction of RuII complexes with liposomes. (a) Eﬀect on MLCT
luminescence intensity of 1 or 2 (lex ¼ 450 nm) with the addition of DOPC
liposomes. Data presented as average of two readings SD. (b) Emission spectra
of 2 (lex ¼ 488 nm) with the addition of DOPC liposomes (background
corrected).
This journal is ª The Royal Society of Chemistry 2013 Chem. Sci., 2013, 4, 4512–4519 | 4515
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wavelength of 2, also validated the imaging compatibility of the
complex with the commonly used FITC uorophore. Immuno-
uorescent co-staining with 2 and calnexin, a calcium-binding
protein located within the ER membrane, shows a clear overlap
within MCF-7 cells (Fig. 5e). This is further conrmed by co-
localization analysis of the two luminophores, showing a strong
overlap of MLCT and FITC emission signals due to 2 and cal-
nexin respectively (Fig. 5f). In contrast to these results, similar
experiments employing immunouorescent labelling with
Golgin-97, a membrane protein located within the Golgi appa-
ratus, demonstrated signicantly poorer co-localization
between FITC and 2 emission signals (Fig. S5†). Taken together,
these results reveal that a signicant proportion of 2 is ER-
localized and the lipophilic RuII complex is targeting this
organelle.
While ER-targeting has been established for luminescent
europium(III),37,38 zinc(II)39,40 and platinum(II)41 coordination
complexes, and a range of metal-based systems have been
postulated to demonstrate such behaviour,21,22,42–46 to the best of
our knowledge this is the rst time that a ruthenium(II) complex
has been denitively proven to be a luminescent cellular probe
for this organelle. Furthermore, as shown in these studies, 2
demonstrates signicant photophysical advantages over many
commercial imaging agents: it has an easily accessible blue
excitation, a large Stokes shi value of 152 nm and a red
emission compatible with other existing uorophores. Based on
these data and our in vitro studies it is highly likely that the
exact molecular target of 2 are lipid membranes and it is this
interaction that enhances the Ru(tpphz)-based luminescence of
the complex through shielding from water.
In addition to light microscopy, RuII polypyridyl compounds
may function as contrast agents for transmission electron
microscopy (TEM) analysis of cellular sections courtesy of the
electron-dense RuII metal centre(s).23,47,48 With this in mind, the
ability of 2 to function as a contrast stain for TEM was also
explored. As shown in Fig. 6, staining xed HeLa cells with 2
facilitates the visualization of internal cellular structure, where
the addition of the RuII complex provides intracellular contrast
levels comparable to cells stained with OsO4, a commonly
employed TEM contrast agent that target lipids. Examining the
intracellular localization of 2 at higher magnication, strong
nuclear membrane and ER staining by 2 are evident while
Fig. 5 Cellular imaging properties of 2. (a) MCF-7 cells stained by 2 after treatment with formaldehyde or ethanol ﬁxation and visualised by MLCT excitation/
emission wavelengths. (b) Emission proﬁle of 2 in formaldehyde-ﬁxed cells (lex ¼ 488 nm). Data presented as average emission of 5 regions of interest (right). (c)
Co-staining with 2 and DNA dye DAPI. (d) Co-localization analysis of 2 and DAPI emission. Regions solely stained by 2 are labelled red, DAPI-exclusive regions blue,
and regions of overlap of the two emission signals white. (e) Co-staining of cells stained with 2 and ER-localized calnexin protein, as visualized by immunoﬂuo-
rescence (FITC-conjugated secondary antibody). (f) Co-localization analysis of 2 and FITC emission where the region of overlapping signals is labelled in white. Scale
bars in b, d, and f ¼ 10 mm.
4516 | Chem. Sci., 2013, 4, 4512–4519 This journal is ª The Royal Society of Chemistry 2013
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mitochondrial inner membrane structure is also dened using
this high resolution technique (Fig. 6, btm right). Notably, 2 does
not show a strong intranuclear contrast signal. These ndings
are in agreement with the light microscopy results in Fig. 5, and
indicate that 2 has potential as a dual-mode cellular imaging
agent for use with both light and electron microscopies.
Live cell uptake and bioactivity
In addition to imaging studies, the biomedical application of
luminescent metal complexes has been of growing interest.49 In
such applications, the luminescent properties of RuII polypyridyl
complexes may serve as tools to examine cellular uptake and
targeting – two key factors in elucidating the mechanism of
action of a potential therapeutic. Accordingly, the live cell uptake
and impact upon cell viability of 2 towards two human cancer
cell lines was investigated. We were particularly interested in
exploring how a lipophilic, kinetically inert RuII compound that
interacts with membranes would aﬀect live cells.
To assess the cytotoxicity of 2, MCF-7 human breast cancer
and HeLa human cervical cancer cells were exposed to a
concentration gradient of 2 and the resultant cell viability
determined by MTT assay. From these data, half-inhibitory IC50
concentrations were extrapolated. The anti-cancer drug
cisplatin was used as a positive control for the cytotoxic
response of each cell line. As indicated by Table 1 and Fig. S6,† 2
was found to demonstrate appreciable cytotoxicity towards both
cell lines, with IC50 values of 7 and 8 mM for MCF-7 and HeLa
cells respectively; for MCF-7 cells this represents a 20-fold
increase in cytotoxicity relative to 1 (IC50 ¼ 138 mM). Examining
the cellular morphology for each cell line exposed to cytotoxic
levels of 2, cell swelling (oncosis), cellular debris and evidence
of intracellular vacuolization were apparent (Fig. S6†). As no
indication of apoptotic cell morphologies (e.g. cell shrinkage/
blebbing/fragmented nuclei) were observed, these changes are
consistent with necrosis being the dominant cell death
pathway, however, more detailed studies would be required to
conrm this hypothesis.
To examine the live cell uptake of 2, MCF-7 cells were incu-
bated with sub-IC50 concentrations of 2 before being visualized
using confocal microscopy. As shown by Fig. 7, complex 2 is
indeed internalized by live MCF-7 cells, where its cellular
localization is observable by MLCT emission. Again, co-staining
with DAPI conrms non-nuclear localization, and closer
inspection reveals the compound is localized in the perinuclear
region (Fig. 7a). This localization prole is in agreement with
the xed cells studies described above; furthermore, these live
cell experiments also indicate that 2 is distributed in discrete
vacuolar regions within the cytoplasm (Fig. 7b). Taken together,
these results are consistent with targeting of the endomem-
brane system, which comprises of not just the ER but also the
nuclear envelope and vacuole structures as well.
Fig. 6 TEM of HeLa cells stained with either OsO4 (top) or 2 (bottom). Labelling:
n ¼ nucleus, nm ¼ nuclear membrane, er ¼ endoplasmic reticulum, m ¼ mito-
chondria, pm ¼ plasma membrane.
Table 1 IC50 values (mM) of 1, 2 and cisplatin towards MCF-7 and HeLa cancer
cell lines (24 h). Data presented as average of three (2) or two (cisplatin) inde-
pendent experiments  SD
Complex
Cell line
MCF-7 HeLa
1 138  6a >200
2 7  2 8  1
Cisplatin 12  3 24  4
a Data from ref. 23.
Fig. 7 Live cell internalization of 2. MCF-7 cells incubated with 2 (5 mM for 24 h)
showing perinuclear (a) and intracellular vacuolar structures (b) stained by the RuII
complex. Co-staining with DAPI is included (right hand column).
This journal is ª The Royal Society of Chemistry 2013 Chem. Sci., 2013, 4, 4512–4519 | 4517
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Given the live cell internalization of 2, we then examined its
cellular uptake mechanism, specically to determine whether 2
is internalized by passive diﬀusion or by energy-dependent
transport. To achieve this, MCF-7 cells were incubated with
solutions of 2 at 37 C or 4 C, the latter conditions being
employed to inhibit active uptake. The relative levels of cellular
MLCT luminescence were then compared. As shown in Fig. 8,
the cellular internalization of 2 is a temperature-dependent
process, with cells incubated at 4 C demonstrating signicantly
lower intracellular levels of 2 compared to cells incubated in
parallel at 37 C. This would indicate that a signicant amount
of cellular internalization of 2 is an active process although the
low intracellular luminescence in cells incubated at 4 C does
suggest that a background level of passive diﬀusion also occurs.
Despite the lipophilicity of 2, it is noteworthy that it is not
internalized solely by passive diﬀusion. While work by Puckett
and Barton demonstrated that increasing the lipophilicity of
RuIIdppz complexes can promote cellular uptake by passive
diﬀusion,14,50 this does not necessarily indicate passive diﬀu-
sion is the dominant mechanism in all cases. Indeed, we have
found active transport to be a common feature in our cellular
uptake studies on mono- and dinuclear RuIItpphz systems that
are internalized rapidly by cells.23,47 Therefore, the results for 2
implying the involvement of an active transport uptake mech-
anism are consistent with this work. This emphasises the
sensitivity to both lipophilicity and structure in the cellular
uptake properties of RuII polypyridyl systems.
It should be pointed out that 2was used as a racemic mixture
within this study. Svensson et al. observed subtle diﬀerences in
the xed cell localization of DNA-targeting dinuclear RuII poly-
pyridyl enantiomers, although no diﬀerence in live cell uptake
was seen.51 It is not clear if this would similarly apply towards a
membrane-interactive complex, however, it would be intriguing
to examine both the spectral and bioactive properties of
resolved stereoisomers of 2.
Although restrictive in live cellular imaging applications, it is
notable that 2 demonstrates signicantly higher cytotoxicity
than the DNA-targeting parent complex 1 towards two cancer
cell lines. Largely due to the precedent set by platinum thera-
peutics, cytotoxic anti-cancer molecules that irreversibly target
DNA have dominated inorganic medicinal chemistry,52
however, there has been growing interest in complexes that
display aﬃnity for other biological targets.53 For example, a
recent report has described a reactive RuII organometallic anti-
cancer compound that operates through the induction of ER
stress.54 In this context, the fact that 2 has a comparable impact
to cisplatin on human breast cancer cell viability and targets
cellular membrane structures, including the ER, is signicant
in extending the scope of biological activities exhibited by
kinetically inert octahedral metal complexes.
Conclusions
In conclusion, we report the design and characterization of the
lipophilic RuII MLCT luminescent complex 2, which targets the
lipid-dense endoplasmic reticulum in cells, where it acts as an
in cellulo imaging agent for this organelle for confocal laser
scanning microscopy and transmission electron microscopy.
From the perspective of bioactivity, we observe a comparable
cytotoxicity to the anti-cancer drug cisplatin, emphasising how
control of the physical properties of this class of complexes can
modulate cellular localization and, as a result, impact upon cell
viability. Combined with our in vitro binding studies, we
conclude the molecular target of 2 is biological membranes and
future studies into the interaction of this complex with specic
membrane structures will provide more detailed insights into
the bioactivity of 2 and its analogues.
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